immune system
• at 7 to 11 months of age
|
• fewer CD23+CD21+IgM+ follicular B cells are detected
|
• fewer CD211hiIgMhiCD1dhi marginal zone B cells are detected
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• following stimulation by anti-IgM or anti-CD40 antibodies, B cell proliferation is reduced
• however, proliferation stimulated by LPS is normal
|
• antibody-mediated response to NP-CG is not as strong ad in wild-type mice
• antibody-mediated response to NP-ficoll is severely impaired
|
• at 7 to 11 months of age, mice develop an autoimmune disease with features similar to systemic lupus erythematosus
|
hematopoietic system
• following stimulation by anti-IgM or anti-CD40 antibodies, B cell proliferation is reduced
• however, proliferation stimulated by LPS is normal
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• fewer CD23+CD21+IgM+ follicular B cells are detected
|
• fewer CD211hiIgMhiCD1dhi marginal zone B cells are detected
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
• at 7 to 11 months of age
|
growth/size/body
• at 7 to 11 months of age
|
cellular
• following stimulation by anti-IgM or anti-CD40 antibodies, B cell proliferation is reduced
• however, proliferation stimulated by LPS is normal
|